EyeCare Partners

02/20/2026

February is Age-Related Macular Degeneration (AMD) Awareness Month and a timely reminder of how early detection, patient education and coordinated care are to key to preserving vision. AMD is a leading cause of central vision loss for millions of adults, and many people may not notice changes until the disease has progressed.

At EyeCare Partners, our clinicians across our practices help guide patients through risk assessment, regular monitoring, treatment options and ongoing support tailored to their needs. We empower our patients and families to protect vision and quality of life. Early and proactive care can make a meaningful difference.

Learn more in the latest blog from EyeCare Associates, an EyeCare Partners practice, and be part of raising awareness this month.

https://www.webeca.com/eye-care-resources/amd-awareness-month

Age-related macular degeneration is a leading cause of vision loss, but with the right management, you can slow progression. Learn more with EyeCare Associates.

02/17/2026

It's National Compliment Day.
We pay a compliment little differently.
Across our network, the best compliments are the same: Healthy eyes. Clear vision. Confident care.
We're proud to support the doctors and teams who deliver that every day.

02/13/2026

Eye care starts with the experts behind the exam.

Eyes can change long before patients notice symptoms, and that’s why the work of eye care professionals matters so much. From early detection to long-term vision health, annual eye exams play a critical role in patient outcomes and preventative care.

We recently shared a blog across many of our practice channels reinforcing why annual eye exams matter, and it’s a reminder of the expertise, clinical judgment, and trust our care teams bring to every visit.

📖 Read the article here:

https://www.clarksoneyecare.com/eye-care-resources/why-you-need-an-annual-eye-exam

To our optometrists, ophthalmologists, PAs, technicians and support teams: Thank you for helping patients protect their vision, often before they even know they need it.

Clarkson Eyecare

Annual eye exams are essential for protecting your vision and identifying eye conditions before they worsen. Learn more about eye exams with Clarkson Eyecare.

02/12/2026

Congratulations to Rupan Trikha, M.D., a fellowship-trained vitreo-retinal surgeon at Monmouth Retina, who, along with his team, performed the first-ever Encelto® implant in New Jersey. This treatment brings a new, FDA-approved option to patients with Macular Telangiectasia Type 2 (MacTel).

This milestone is also a full circle moment for Dr. Trikha, who participated in a 2007 clinical trial on the Encelto implant delivery system during his fellowship.

Until now, patients with MacTel Type 2 had no approved therapy to address the underlying degeneration, only management of secondary complications. Encelto changes that conversation by offering a way to preserve remaining vision.

As part of the EyeCare Partners network, this milestone reflects our shared commitment to advancing retinal care through thoughtful patient selection, precise surgical ex*****on and close collaboration between referring providers and specialized surgical teams.

02/11/2026

We’re proud to share that Gemini Bogie, M.D., Joshua Jones, M.D., and Kayla Unsell, M.D., of Precision Vision Oklahoma , have been named 2026 Top Doctors by 405 Magazine. Dr. Unsell was also recognized as a Rising Star, highlighting her growing leadership and impact in eye care.

These peer-nominated honors reflect the respect of fellow physicians. We’re grateful to 405 Magazine and proud to support our physicians as they care for patients across Oklahoma City every day.

https://issuu.com/sliceok/docs/january_2026_e32bae0a2445ae

02/08/2026

👓 Which do you see better: one or two?

👀 1️⃣ 🏈 Patriots
👀 2️⃣ 🏈 Seahawks

Cast your vote in the comments and don’t forget — clear vision makes every 4th down look better!

02/03/2026

February is Age-Related Macular Degeneration (AMD) Awareness Month.
AMD is one of the leading causes of serious vision loss in adults over 60—and it’s becoming more common as our population ages. In this video, Dan Miller, M.D., Ph.D., Ophthalmology President and Executive Medical Officer at EyeCare Partners, discusses dry and wet AMD, why early identification matters and how annual eye exams play a critical role in protecting vision.

https://www.youtube.com/watch?v=xiyfEdGh4G8

Dan Miller, M.D., Ph.D.: "Age-related macular degeneration is one of the leading causes of serious vision loss in patients over the age of 60. With our aging...

02/02/2026

Punxsutawney Phil checks the weather once a year.
EyeCare Partners focuses on vision health all year long.
Consistent, preventive eye care drives better patient outcomes and supports the long-term vision health of the communities we serve.

01/30/2026

Glaucoma care is evolving—and so are the tools clinicians have to manage it.

In this episode of Doc2Doc, eye care leaders come together for a candid, peer-to-peer conversation about how Direct Selective Laser Trabeculoplasty (DSLT) and the iDose
implant are showing up in real clinical practice today.

Hosted by Katie Rachon, O.D., F.A.A.O., Dipl. ABO, and Constance Okeke, M.D., of Virginia Eye Consultants, the discussion features expert perspectives from Anup Khatana, MD, (Cincinnati Eye Institute) and Michael Stiles, M.D.(Stiles Eyecare Excellence).

In this episode, clinicians explore:
➡️ How DSLT and iDose are being integrated into glaucoma treatment plans.
➡️ Which patients may benefit most—and why timing matters.
➡️ What real-world outcomes are showing beyond clinical trials.

As we continue to observe Glaucoma Awareness Month, EyeCare Partners is proud to share conversations that help eye care professionals stay informed, confident and prepared for what’s next in interventional glaucoma care.

Watch the full episode:
https://www.youtube.com/watch?v=Ria_wKJ1ElY

01/21/2026

This episode of Doc2Doc features a dynamic, clinician-to-clinician conversation on two emerging technologies in glaucoma care: Direct Selective Laser Trabeculoplasty and the iDose implant.

Hosted by Katie Rachon, O.D., F.A.A.O., Dipl. ABO, and Constance Okeke, MD, MSCE, of Virginia Eye Consultants, the discussion includes expert insights from Anup Khatana, MD, of Cincinnati Eye Institute and Michael Stiles, M.D., of Stiles Eyecare Excellence.

What providers will gain:
➡️ Practical perspectives on clinical application of DSLT and iDose.
➡️ Patient selection considerations.
➡️ Real-world outcomes and workflow implications.
➡️ Guidance for navigating the evolving landscape of interventional glaucoma treatment.

Watch the episode: https://www.youtube.com/watch?v=Ria_wKJ1ElY

Listen to the episode: https://www.buzzsprout.com/2208134/episodes/17940885-doc2doc-podcast-october-2025-innovations-in-glaucoma-care-dslt-and-idose-implant

As we recognize Glaucoma Awareness Month, EyeCare Partners is proud to share conversations that equip eye care professionals with timely insights and evidence-informed perspectives.

01/20/2026

Today, we celebrate four remarkable professionals whose careers have left a lasting impact on patients, colleagues and the communities they served.

➡️ John Barletta, M.D., Huron Ophthalmology
➡️ George Georgilis, O.D., Clarkson Eyecare
➡️ Paul Moyer, M.D., CVP Physicians
➡️ Jill Newton, MPA, PA-C, COA, Virginia Eye Consultants

Your commitment to patients and teams has helped elevate care and inspire those who follow in your footsteps. Join us in wishing them a well-earned and fulfilling retirement.

01/16/2026

Glaucoma remains one of the leading causes of irreversible vision loss, largely due to its asymptomatic progression in early stages.

Early detection through routine comprehensive exams is critical to slowing disease progression and preserving visual function. Consistent monitoring allows for timely intervention and individualized management plans that support long-term outcomes.

This Glaucoma Awareness Month, we recognize the essential role of vigilance, education and early diagnosis in protecting patients’ vision.